Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shivani Soni

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2022
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trialsJingyuan Wang, Yi Xiao, Fotios Loupakis, et al.
Oncogene|January 17, 2023
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directionsPriya Jayachandran, Francesca Battaglin, Carly Strelez, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2020
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trialsMartin D Berger, Yan Ning, Sebastian Stintzing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/CetuximabMartin D Berger, Sebastian Stintzing, Volker Heinemann, et al.
Molecular Cancer Therapeutics|October 10, 2020
Molecular Characterization of Appendiceal Goblet Cell CarcinoidHiroyuki Arai, Yasmine Baca, Francesca Battaglin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2019
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, et al.
NPJ Precision Oncology|September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancerJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Neoplasia (New York, N.Y.)|November 7, 2025
Age-diet interactions significantly influence intratumoral gene expression, gut microbiome signature and tumor microenvironment in colorectal cancerShivani Soni, Pooja Mittal, Jae Ho Lo, et al.
JCO Precision Oncology|April 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast CancerPriya Jayachandran, Sachin K Deshmukh, Sharon Wu, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2022
Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trialsJingyuan Wang, Yi Xiao, Fotios Loupakis, et al.
Oncogene|January 17, 2023
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directionsPriya Jayachandran, Francesca Battaglin, Carly Strelez, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2020
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trialsMartin D Berger, Yan Ning, Sebastian Stintzing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/CetuximabMartin D Berger, Sebastian Stintzing, Volker Heinemann, et al.
Molecular Cancer Therapeutics|October 10, 2020
Molecular Characterization of Appendiceal Goblet Cell CarcinoidHiroyuki Arai, Yasmine Baca, Francesca Battaglin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2019
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, et al.
NPJ Precision Oncology|September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancerJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Neoplasia (New York, N.Y.)|November 7, 2025
Age-diet interactions significantly influence intratumoral gene expression, gut microbiome signature and tumor microenvironment in colorectal cancerShivani Soni, Pooja Mittal, Jae Ho Lo, et al.
JCO Precision Oncology|April 28, 2025
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast CancerPriya Jayachandran, Sachin K Deshmukh, Sharon Wu, et al.
Pageof 9